BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Influenza
,
Prostate
,
Autoimmunity
,
Rapamycin
,
rs2476601
,
ZBTB7A
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
MAdCAM- 1
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for MAdCAM- 1
Explore Curated Studies Results
Literature
Most Relevant Literature
MAdCAM-1 mediates retinal neuron degeneration in experimental colitis through recruiting gut-homing …
Antibody secreting cells are critically dependent on integrin α4β7/MAdCAM-1 for intestinal recruitme…
MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated…
Bile acids modulate colonic MAdCAM-1 expression in a murine model of combined cholestasis and coliti…
Role of MAdCAM-1-Expressing High Endothelial Venule-Like Vessels in Colitis Induced in Mice Lacking …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness
Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease
Study of Vedolizumab Following Multiple Intravenous Doses in Patients With Ulcerative Colitis
Efficacy of Vedolizumab in Crohn's Disease Patients Naive to Biological Therapy
Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ